Malaysia-based private equity firm and return backer Xeraya Capital has joined the $120-million investment round for US-headquartered Rapid Micro Biosystems Inc, a provider of rapid microbial detection technology for biopharma manufacturing.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in